DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹55,904 Cr | ₹47,594 Cr | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr |
What is the latest Total Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹55,904 Cr |
| Mar2025 | ₹47,594 Cr |
| Mar2024 | ₹37,806 Cr |
| Mar2023 | ₹31,580 Cr |
| Mar2022 | ₹28,470 Cr |
How is Total Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹55,904 Cr | 17.46 | |
| Mar2025 | ₹47,594 Cr | 25.89 | |
| Mar2024 | ₹37,806 Cr | 19.72 | |
| Mar2023 | ₹31,580 Cr | 10.92 | |
| Mar2022 | ₹28,470 Cr | - | |
Compare Total Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹112,701.2 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
| MANKIND PHARMA | ₹102,797.0 Cr | 8.1% | -2.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 3.6% |
8% |
4.2% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses